Stay updated on Pembrolizumab vs Docetaxel in NSCLC: Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs Docetaxel in NSCLC: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs Docetaxel in NSCLC: Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The page shows Revision: v3.6.3, replacing the previous Revision: v3.6.2. It reflects a small backend update with no changes to the study details.
    Difference
    0.1%
    Check dated 2026-07-03T22:10:55.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.2, replacing the previous v3.6.0, signaling a minor page revision. This update appears to be a label-only change and does not modify the study content or results.
    Difference
    0.1%
    Check dated 2026-06-26T20:38:22.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The page now indicates recruitment is closed for participants, and new help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study), along with a formatting adjustment from 'Intervention / Treatment' to 'Intervention/Treatment' and a new revision version (v3.6.0).
    Difference
    0.4%
    Check dated 2026-06-12T13:27:13.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.5.4 to v3.5.5, indicating a new internal revision was applied. This update does not modify visible study information.
    Difference
    0.1%
    Check dated 2026-06-05T10:37:54.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Added a new page revision label 'Revision: v3.5.4' and removed the previous 'Revision: v3.5.3'. This indicates a minor update to the page's versioning metadata without altering the study content or available information.
    Difference
    0.1%
    Check dated 2026-05-15T04:14:33.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.5.2 to v3.5.3, signaling a minor platform/software update to the study page rather than a change to study content or results. No study data, eligibility criteria, or outcomes are altered by this update.
    Difference
    0.1%
    Check dated 2026-04-30T17:50:06.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs Docetaxel in NSCLC: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Docetaxel in NSCLC: Clinical Trial page.